Your browser doesn't support javascript.
loading
Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds.
Ruengsatra, Tanachote; Meeprasert, Arthitaya; Rattanangkool, Eakkaphon; Deesiri, Sirikan; Srisa, Jakkrit; Udomnilobol, Udomsak; Dunkoksung, Wilasinee; Chuaypen, Natthaya; Kiatbumrung, Rattanaporn; Tangkijvanich, Pisit; Vimolmangkang, Sornkanok; Pudhom, Khanitha; Prueksaritanont, Thomayant.
Affiliation
  • Ruengsatra T; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Meeprasert A; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Rattanangkool E; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Deesiri S; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Srisa J; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Udomnilobol U; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Dunkoksung W; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Chuaypen N; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Kiatbumrung R; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University Bangkok Thailand.
  • Tangkijvanich P; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Vimolmangkang S; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University Bangkok Thailand.
  • Pudhom K; Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR), Chulalongkorn University 254 Phayathai Rd, Prathumwan Bangkok 10330 Thailand thomayant.p@pharm.chula.ac.th.
  • Prueksaritanont T; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University Bangkok Thailand.
RSC Adv ; 13(41): 29004-29022, 2023 Sep 26.
Article in En | MEDLINE | ID: mdl-37807973
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: RSC Adv Year: 2023 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: RSC Adv Year: 2023 Document type: Article Country of publication: Reino Unido